- Home
- IR vs RMD Comparison
IR vs RMD Comparison
Compare IR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IR
- RMD
- Stock Information
- Founded
- IR 1859
- RMD 1989
- Country
- IR United States
- RMD United States
- Employees
- IR N/A
- RMD N/A
- Industry
- IR Industrial Machinery/Components
- RMD Medical/Dental Instruments
- Sector
- IR Industrials
- RMD Health Care
- Exchange
- IR Nasdaq
- RMD Nasdaq
- Market Cap
- IR 34.2B
- RMD 31.8B
- IPO Year
- IR N/A
- RMD 1995
- Fundamental
- Price
- IR $72.05
- RMD $212.92
- Analyst Decision
- IR Buy
- RMD Buy
- Analyst Count
- IR 10
- RMD 11
- Target Price
- IR $99.40
- RMD $253.88
- AVG Volume (30 Days)
- IR 3.4M
- RMD 1.2M
- Earning Date
- IR 05-01-2025
- RMD 04-23-2025
- Dividend Yield
- IR 0.11%
- RMD 1.00%
- EPS Growth
- IR 8.42
- RMD 40.24
- EPS
- IR 2.06
- RMD 8.47
- Revenue
- IR $7,235,000,000.00
- RMD $4,926,773,000.00
- Revenue This Year
- IR $6.90
- RMD $10.09
- Revenue Next Year
- IR $5.33
- RMD $7.39
- P/E Ratio
- IR $34.98
- RMD $24.97
- Revenue Growth
- IR 5.22
- RMD 9.38
- 52 Week Low
- IR $65.61
- RMD $172.19
- 52 Week High
- IR $106.03
- RMD $263.05
- Technical
- Relative Strength Index (RSI)
- IR 39.94
- RMD 44.80
- Support Level
- IR $70.76
- RMD $206.74
- Resistance Level
- IR $74.36
- RMD $217.38
- Average True Range (ATR)
- IR 3.72
- RMD 8.87
- MACD
- IR 0.06
- RMD 0.32
- Stochastic Oscillator
- IR 39.13
- RMD 51.32
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.
About RMD ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.